Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: November 13, 2018
Context: The registrant is an emerging growth company. This filing serves as a Regulation FD disclosure to announce upcoming investor and analyst presentations. The company intends to utilize the material contained in Exhibit 99.1 (Investor Presentation dated November 2018) for these communications.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding investor communications and does not contain audited financial statements or specific financial data points.
Material Changes
No material changes to financial performance or operations are reported in this specific filing text. The document solely references the existence of an investor presentation (Exhibit 99.1) without detailing the content or any comparative period changes.
Guidance, Outlook, and Risks
- Management Commentary: Executive officers have scheduled upcoming presentations for investors and analysts.
- Legal Status of Information: The information furnished in this Item 7.01 and the referenced Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
- Risks and Contingencies: No specific risks or contingencies are detailed in the text of this 8-K.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated November 2018) for actual financial data, guidance, and strategic updates, as this 8-K only references the exhibit.
- Confirm the company's status as an emerging growth company and its election regarding the extended transition period for new accounting standards.
- Note that the information in this filing is not incorporated by reference into other SEC filings unless specifically cited.